Grindeks and its subsidiary Kalceks are currently exhibiting at the world’s largest pharma trade show CPhI Worldwide 2018 that takes place in Feria de Madrid,...
Šodien, 30. augustā, akciju sabiedrības Grindeks „Nasdaq Riga” iesniegtie 2018. gada pirmā pusgada nerevidētie konsolidētie finanšu pārskati liecina, ka Koncerna apgrozījums 2018. gada pirmajā pusgadā...
On Wednesday, August 22, the leaders of Latvian science and industry – JSC Grindeks and Latvian Institute of Organic Synthesis (IOS) – strengthened their long-lasting...
JSC Grindeks announces, it has expanded its territory and acquired a plot of land with buildings located in Riga, Krustpils street 63 for the development...
Today, on 31 May, the JSC Grindeks submitted the non-audited consolidated financial statements for the first three months of 2018 to “Nasdaq Riga”. Non-audited financial...
JSC Grindeks informs that submission of audited consolidated financial statements of 2017 of JSC Grindeks was delayed due to the fact despite there were written...
The State Revenue Service of the Republic of Latvia has annually awarded the biggest Latvian taxpayers of 2017 during a ceremony held on Thursday, April...
Today, on 28 February, the JSC Grindeks submitted the non-audited consolidated financial statements of 2017 to Nasdaq Riga. Non-audited financial results indicate that in 2017...
JSC Grindeks announced the company’s Supervisory Council has re-elected Juris Bundulis as its Chairman of the Board and elected Ph.D. Juris Hmelnickis in the Board...
Today, on 27 November, the JSC Grindeks submitted the non-audited consolidated financial statements for the first nine months of 2017 to “Nasdaq Riga”. Non-audited financial...
